[期刊论文]


Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.

作   者:
Carlos Alberto Gomez-Roca;Carlos Alberto Gomez-Roca;Philippe Alexandre Cassier;Philippe Alexandre Cassier;Antoine Italiano;Antoine Italiano;Michael Cannarile;Michael Cannarile;Carola Ries;Carola Ries;Anne Brillouet;Anne Brillouet;Claudia Mueller;Claudia Mueller;Anna-Maria Jegg;Anna-Maria Jegg;Georgina Meneses-Lorente;Georgina Meneses-Lorente;Monika Baehner;Monika Baehner;Keelara Abiraj;Keelara Abiraj;Delphine Loirat;Delphine Loirat;Maud Toulmonde;Maud Toulmonde;Sandra P. D'Angelo;Sandra P. D'Angelo;Kristy Weber;Kristy Weber;Mario Campone;Mario Campone;Dominik Ruettinger;Dominik Ruettinger;Jean-Yves Blay;Jean-Yves Blay;Jean-Pierre Delord;Jean-Pierre Delord;Christophe Le Tourneau;Christophe Le Tourneau;

出版年:2015

页     码:3005 - 3005
出版社:American Society of Clinical Oncology (ASCO)


摘   要:

暂无



关键字:

暂无


所属期刊
Journal of Clinical Oncology
ISSN: 0732-183X
来自:American Society of Clinical Oncology (ASCO)